よむ、つかう、まなぶ。
資 料４－１ 令和３年度第６回安全技術調査会の審議結果について (324 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_26025.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会血液事業部会（令和4年度第1回 6／8）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
47. Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B, Derex L, Lichy C,
Masjuan J, Massaro A, Matamala G, Poli S, Saadatnia M, Stolz E, Viana-Baptista M, Stam J, Bousser MG;
Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators:
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of
individual patient data. Stroke. 2011; 42: 2825-2831. doi: 10.1161/STROKEAHA.111.615393.
48. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I,
Masuhr F, Aguiar de Sousa D, Stam J; European Stroke Organization. European Stroke Organization
guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European
Academy of Neurology. Eur J Neurol. 2017; 24: 1203-1213. doi: 10.1111/ene.13381.
49. Davoudi V, Keyhanian K, Saadatnia M. Risk factors for remote seizure development in patients with
cerebral
vein
and
dural
sinus
thrombosis.
Seizure.
2014;
23:
135-139.
doi:
10.1016/j.seizure.2013.10.011.
50. Price M, Günther A, Kwan JSK. Antiepileptic drugs for the primary and secondary prevention of seizures
after intracranial venous thrombosis. Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD005501. doi:
10.1002/14651858.CD005501.pub4.
51. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Early seizures in
cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008; 39: 11521158. doi: 10.1161/STROKEAHA.107.487363.
23
322
Masjuan J, Massaro A, Matamala G, Poli S, Saadatnia M, Stolz E, Viana-Baptista M, Stam J, Bousser MG;
Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators:
Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of
individual patient data. Stroke. 2011; 42: 2825-2831. doi: 10.1161/STROKEAHA.111.615393.
48. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I,
Masuhr F, Aguiar de Sousa D, Stam J; European Stroke Organization. European Stroke Organization
guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European
Academy of Neurology. Eur J Neurol. 2017; 24: 1203-1213. doi: 10.1111/ene.13381.
49. Davoudi V, Keyhanian K, Saadatnia M. Risk factors for remote seizure development in patients with
cerebral
vein
and
dural
sinus
thrombosis.
Seizure.
2014;
23:
135-139.
doi:
10.1016/j.seizure.2013.10.011.
50. Price M, Günther A, Kwan JSK. Antiepileptic drugs for the primary and secondary prevention of seizures
after intracranial venous thrombosis. Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD005501. doi:
10.1002/14651858.CD005501.pub4.
51. Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Early seizures in
cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke. 2008; 39: 11521158. doi: 10.1161/STROKEAHA.107.487363.
23
322